CD19 selection improves the sensitivity of B cell lymphoma detection

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 2, 1998, Pages 159-168

  Pugh, R E ^a   Bitter, M A ^a   Shpall, E J ^a   Hami, L S ^a   Wolf, D M ^a   Franklin, W A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN;

ANTIGEN DETECTION; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENOME; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOMA; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR CELL;

ANTIGENS, CD19; DNA; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LYMPHOMA, B-CELL; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0031977260     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Phillip, T., Guglielmi, C., Hagenbeek, A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N. Engl. J. Med. 333:1540, 1995.
2. Kessinger, A. & Armitage, J.O. The evolving role of autologous peripheral stem cell transplantation following high dose therapies for malignancies. Blood 77:211, 1991.
3. Demuynck, H., Delforge, M., Zachee, P., et al. An update on peripheral blood progenitor cell transplantation [Review]. Ann. Hematol. 71:29, 1995.
4. Bastion, Y., Brice, P., Haioun, C., et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 86:3257, 1995.
5. Santini, G., Congiu, A.M. & Nati, S. Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement. Leukemia 10 (Suppl 2):s88, 1996.
6. Kanz, L., Brugger, W. & Mertelsmann, R. Haematopoietic growth factors and peripheral blood stem cells as supportive agents in dose intensification [Review]. Eur. J. Cancer 29A(Suppl 5):S23, 1993.
7. Brenner, M.K., Rill, D.R., Moen, R.C., et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993.
8. Selvaggi, K.J., Wilson, J.W., Mills, L.E., et al. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow. Blood 83:1698, 1994.
9. Rill, D.R., Santana, V.M., Roberts, W.M., et al. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380, 1994.
10. Deisserorth, A.B., Zu, Z., Caxton, D., et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994.
11. Brugger, W., Brass, K.J., Glatt, M., et al. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636, 1994.
12. Vora, A.J., Toh, C.H., Peel, J., et al. Use of granulocyte colony-stimulating factor (G-CSF) for mobilizing peripheral blood stem cells: Risk of mobilizing clonal myeloma cells in patients with bone marrow infiltration. Br. J. Haematol. 86:180, 1994.
13. Zhang, X.G., Bataille, R., Jourdan, M., et al. Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells. Blood 78:539, 1991.
14. Philip, T., Guglielmic, C., Hagenbeek, A., et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N. Engl. J. Med. 333:1540, 1995.
15. Weiss, L.M., Warnke, R.A., Sclar, J., et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N. Engl. J. Med. 317:1185, 1987.
16. Ngan, B.Y., Chen, L.Z., Weiss, L.M., et al. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N. Engl. J. Med. 318:1638, 1988.
17. Aisenberg, A.C., Wilkes, B.M. & Jacobson, J.O. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 71:969, 1988.
18. Lee, M.S., Blick, M.B. & Pathak, S. The gene located at the chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas. Blood 70:90, 1987.
19. Yunis, J.J., Oken, M.M., Kaplan, M.E., et al. Distinctive chromosomal abnormalities in histological subtypes of non-Hodgkin's lymphomas. N. Engl. J. Med. 307:1231, 1982.
20. Vaux, D.L., Cory, S. & Adams, J.M. Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988.
21. Cleary, M.L. & Sklar, J. Nucleotide sequence of a t(14;18) chromosomal breakpoiont in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 82:7439, 1985.
22. Cleary, M.L., Galili, N. & Sklar, J. Detection of a second t(14;18) breakpoint cluster region in follicular lymphomas. J. Exp. Med. 164:315, 1986.
23. Berinstein, N.L., Reis, M.D., Ngan, B.Y., et al. Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advancedstage follicular lymphoma. J. Clin. Oncol. 11:1344, 1993.
24. Stetlet-Stevenson, M., Raffeld, M., Cohen, P., et al. Detection of occult follicular lymphoma by specific DNA amplification. Blood 72:1822, 1988.
25. Gribben, J.G., Freedman, A.S., Woo, S.D., et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991.
26. Macintyre, E.A., Belanger, C., Debert, C., et al. Detection of clonal CD34+194- progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. Blood 86:4691, 1995.
27. Lee, M.S., Chang, K.-S., Cabanillas, F., et al. Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237:175, 1987.
28. Gribben, J.G., Freedman, A.S., Neuberg, D., et al. Immunologic purging of marrow assessed by PCR before autologous transplantation for B-cell lymphoma. N. Engl. J. Med. 325:1525, 1991.
29. Hétu, F., Coutlée, F. & Roy, D.C. A non-isotopic nested polymerase chain reaction method to quantitate minimal residual disease in patients with non-Hodgkin's lymphoma. Mol. Cell. Probes 8:499, 1994.
30. H translocations in human blood and organ samples by quantitative polymerase chain reaction assay. Cancer Res. 55:2876, 1995.
31. Liu, Y., Hernandez, A.M., Shibata, D., et al. BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA 91:8910, 1994.
32. Limpens, J., Stad, R., Vos, C., et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528, 1995.
33. H rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J. Clin. Oncol. 14:1333, 1996.
34. Sharp, J.G., Kessiger, A., Mann, S., et al. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lympoma based on the presence of tumor in the marrow or infused hematopoietic harvest. J. Clin. Oncol. 14:214, 1996.
35. Freedman, A.S., Gribben, J.G., Neuberg, D., et al. High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 88:2780, 1996.
36. Gribben, J.G., Neuberg, D., Freedman, A.S., et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993.
37. Gribben, J.G., Neuberg, D., Barber, M., et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994.